Apellis Pharmaceuticals, Inc. (FRA:1JK)
20.69
+0.03 (0.12%)
At close: Jan 2, 2026
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of €2.97 billion as of January 9, 2026. Its market cap has decreased by -25.26% in one year.
Market Cap
2.97B
Enterprise Value
2.97B
Revenue
866.28M
Ranking
n/a
PE Ratio
77.45
Stock Price
€20.69
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from 593.77M to 2.97B, an increase of 400.11%. That is a compound annual growth rate of 21.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 2.97B | 9.70% |
| Dec 31, 2025 | 2.71B | -29.40% |
| Dec 31, 2024 | 3.83B | -40.26% |
| Dec 29, 2023 | 6.42B | 19.95% |
| Dec 30, 2022 | 5.35B | 32.19% |
| Dec 31, 2021 | 4.05B | 14.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |